Close

News

Lonza to Partner with Capricor Therapeutics for the Development of Duchenne Muscular Dystrophy Cell Therapy

Lonza and Capricor Therapeutics, a US-based clinical-stage biotechnology company, announced on Jan. 12, 2020 that they are entering into an agreement for the development of CAP-1002, Capricor's clinical cell therapy that uses allogeneic cardiosphere-derived cells technology for the treatment...

Bharat Biotech signs agreement with Precisa Medicamentos to supply Covaxin to Brazil

Bharat  Biotech announced  that  it  has  signed  an agreement  with Precisa Medicamentos for the supplies of COVAXIN™ to Brazil. A team from Precisa Medicamentos has visited the Bharat Biotech facility last week to discuss potential export possibilities of COVAXIN™, India’s...

US FDA grants emergency use authorization to Quanterixs Simoa SARS-CoV-2 N protein antigen test

Quanterix Corporation, a company digitizing biomarker analysis to advance the science of precision health, announced that the Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for its Simoa SARS-CoV-2 N Protein Antigen Test that can...

Softbox appoints new Technical Solutions Specialist to further extend technical support to customers

Softbox, a leading global innovator and provider of passive temperature controlled packaging solutions for the pharmaceutical, life science and cold chain logistics industries, has announced the appointment of Matthew Tomkinson as a Technical Solutions Specialist. Matt joins Softbox’s Technical Solutions...

NeuroRx, Relief, and Quantum Leap announce the inclusion of ZYESAMI in the I-SPY COVID-19 Trial

NeuroRx, Inc. and RELIEF THERAPEUTICS Holding AG, and the Quantum Leap Healthcare Collaborative of San Francisco announce that NeuroRx and QLHC have signed a Clinical Trial Participation Agreement for the inclusion of ZYESAMI™ in the I-SPY COVID-19 Clinical Trial....

UNICEF, WHO, IFRC and MSF announce the establishment of a global Ebola vaccine stockpile

The four leading international health and humanitarian organizations announced today the establishment of a global Ebola vaccine stockpile to ensure outbreak response. The effort to establish the stockpile was led by the International Coordinating Group (ICG) on Vaccine Provision, which...

Abzena announces opening of new biologics GMP manufacturing site with up to 12 X 2000L bioreactors

Abzena, a Global Partner Research Organization for integrated bench to market solutions for biologics and bioconjugates, has announced the addition of a 6th Global site that will augment cGMP manufacturing capacity for mammalian biologics. This expansion is driven by...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »